Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul 21;76(3):303-305.
doi: 10.1016/j.jacc.2020.05.052.

Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half

Janette F Strasburger  1 , Annette Wacker-Gussmann  2
Affiliations
Editorial

Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half

Janette F Strasburger et al. J Am Coll Cardiol. .
No abstract available

Keywords: anti-SSA/Ro antibodies; congenital heart block; hydroxychloroquine; magnetocardiography; neonatal lupus; prevention.

PubMed Disclaimer

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

References

    1. Izmirly P., Kim M., Friedman D.M. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers. J Am Coll Cardiol. 2020;76:292–302. - PMC - PubMed
    1. Fredi M., Andreoli L., Bacco B. First report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) Front Cardiovasc Med. 2019;6:11. - PMC - PubMed
    1. Askanase A.D., Friedman D.M., Copel J. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus. 2002;11:145–151. - PubMed
    1. Moak J.P., Barron K.S., Hougen T.J. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001;37:238–242. - PubMed
    1. Jaeggi E., Laskin C., Hamilton R., Kingdom J., Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010;55:2778–2784. - PubMed

Supplementary concepts